A DOUBLE-BLIND, RANDOMIZED, CONTROLLED PHASE III STUDY TO ASSESS THE PROPHYLAC

评估预防效果的双盲、随机、对照 III 期研究

• 批准号: 7952038
• 负责人: Gregory James Mertz
• 金额: $ 7.43万
• 依托单位: UNIVERSITY OF NEW MEXICO
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-12-01 至 2009-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7952038
• 关键词: Clinical Research; Computer Retrieval of Information on Scientific Projects Database; Development; Double-Blind Method; Funding; Grant; Herpesvirus 1; Human Herpesvirus 2; Institution; New Mexico; Phase III Clinical Trials; Randomized; Research; Research Personnel; Resources; Source; United States National Institutes of Health; Universities; Vaccines; Woman; genital herpes

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The main purpose of this research is to determine whether the study vaccine protects women who are HSV-1 [herpes simplex virus] and HSV-2 negative against the development of genital herpes

该子项目是利用 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 本研究的主要目的是确定研究疫苗是否能保护HSV-1 [单纯疱疹病毒]和HSV-2阴性的女性免受生殖器疱疹的发展